Resorbable Pouches for Cardiac Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing bacterial contamination and infections associated with implantable medical devices (IMDs) during and after surgery are inadequate, as existing antimicrobial coatings and infection control measures have limited effectiveness in preventing microbial colonization and scarring, and non-resorbable materials complicate device replacement.
Innovation Solution
Development of biodegradable and resorbable polymer pouches that encapsulate IMDs, incorporating antimicrobial, anti-inflammatory, and anesthetic agents to prevent bacterial growth, reduce scarring, and provide pain relief, while being fully resorbable to simplify future device removal.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-resorbable materials are used for device pouches, then device stability and long-term protection are improved, but device replacement becomes complicated and fibrous tissue embedding occurs
Solution Approach 1:
The pouch material transitions from permanent non-resorbable state to temporary resorbable state, changing the temporal parameter of material persistence. The pouch provides protection during the critical healing period then naturally degrades, eliminating the need for surgical removal and avoiding fibrous embedding while maintaining reliability when needed.
Solution Approach 2:
The pouch is designed as a temporary protective structure that is intentionally discarded after serving its purpose. The resorbable material naturally degrades and is absorbed by the body, eliminating the need for surgical removal and avoiding long-term foreign body complications while providing necessary initial protection.
2Object-affected harmful factors
If antimicrobial coatings are applied to devices, then bacterial contamination is reduced, but microbial colonization still occurs during and after surgery
Solution Approach 1:
The pouch combines resorbable polymer material with embedded antimicrobial drugs to create a composite structure. This provides both mechanical protection and chemical antimicrobial action, addressing the limitation of surface coatings by integrating multiple protective mechanisms within a single resorbable system.
Solution Approach 2:
The pouch is pre-loaded with antimicrobial drugs that are released during the critical early post-operative period when infection risk is highest. This preliminary protective action occurs before significant microbial colonization can establish, providing proactive infection prevention rather than reactive treatment.
3Object-affected harmful factors
If traditional infection control measures are used, then surgical site protection is provided, but scarring and fibrosis still occur around the device
Solution Approach 1:
The resorbable pouch acts as a temporary intermediary barrier between the implantable device and the host tissue. It provides a protective interface during healing that prevents direct tissue-device contact and foreign body reaction, then naturally degrades without causing chronic inflammation or fibrosis, unlike permanent materials.
Solution Approach 2:
The pouch material's key parameter is its temporary persistence - it remains intact during surgery and early healing to provide protection, then undergoes controlled degradation. This temporal parameter change allows it to provide surgical site protection while avoiding long-term foreign body reactions that cause scarring and fibrosis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The pouches effectively reduce bacterial colonization and scarring, provide controlled drug release for pain management and infection prevention, and facilitate easier replacement of IMDs by being fully resorbable, thereby improving surgical outcomes and patient safety.
Implementation Method 1
The resorbable polymer matrices of the invention are capable of releasing one or more drugs into surrounding bodily tissue and proximal to the device
Implementation Method 2
biodegradable and resorbable polymers used in present invention
Data Source
Figure 1~2
Figure 3A
Figure 3B
AI summary
Biodegradable and resorbable polymer pouches are described for use with cardiac rhythm mamagent devices (CRMs) and other implantable medical devices (IMDs), i.e., a pouch, covering, or other receptacle capable of encasing, surrounding and/or holding the CRM or other IMD for the purpose of securing it in position, inhibiting or reducing bacterial growth, providing pain relief and/or inhibiting scarring or fibrosis on or around the CRM or other IMD. Optionally, the biodegradable and resorbable pouches of the invention include one or more drugs in the polymer matrix to provide prophylactic effects and alleviate side effects or complications associated with the surgery or implantation of the CRM or other IMD.